Heska Corp. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
78,339.00
89,837.00
104,597.00
130,083.00
129,341.00
127,446
Cost of Goods Sold (COGS) incl. D&A
47,539.00
54,122.00
60,384.00
76,191.00
71,080.00
70,808
Gross Income
30,800.00
35,715.00
44,213.00
53,892.00
58,261.00
56,638
SG&A Expense
31,049.00
32,804.00
35,656.00
37,359.00
40,042.00
45,844
EBIT
249.00
2,911.00
8,557.00
16,533.00
18,219.00
10,794
Unusual Expense
1,181.00
-
-
-
-
7,000
Non Operating Income/Expense
16.00
55.00
102.00
7.00
228.00
62
Interest Expense
74.00
206.00
200.00
160.00
245.00
310
Pretax Income
1,393.00
2,950.00
8,427.00
16,504.00
18,369.00
3,807
Income Tax
454.00
1,351.00
2,908.00
4,339.00
8,913.00
2,115
Consolidated Net Income
939.00
1,599.00
5,519.00
12,165.00
9,456.00
5,850
Net Income
1,196.00
2,603.00
5,239.00
10,508.00
9,953.00
5,850
Net Income After Extraordinaries
1,196.00
2,603.00
5,239.00
10,508.00
9,953.00
5,850
Net Income Available to Common
1,196.00
2,603.00
5,239.00
10,508.00
9,953.00
5,850
EPS (Basic)
0.21
0.41
0.74
1.43
1.30
0.74
Basic Shares Outstanding
5,755.00
5,951.00
6,509.00
6,783.00
7,026.00
7,220
EPS (Diluted)
0.21
0.41
0.74
1.43
1.30
0.74
Diluted Shares Outstanding
5,755.00
6,409.00
7,074.00
7,361.00
7,642.00
7,856
EBITDA
2,248.00
6,623.00
12,744.00
21,178.00
22,973.00
15,389
Non-Operating Interest Income
127.00
190.00
172.00
124.00
167.00
261
Minority Interest Expense
257.00
1,004.00
280.00
1,657.00
497.00
-

About Heska

View Profile
Address
3760 Rocky Mountain Avenue
Loveland Colorado 80538
United States
Employees -
Website http://www.heska.com
Updated 07/08/2019
Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through the Core Companion Animal Health; and Other Vaccines, and Pharmaceuticals and Products segments. The Core Companion Animal Health segment includes point of care diagnostic laboratory instruments and supplies, imaging instruments, software, and services as well as single use diagnostic and other tests, pharmaceuticals, and vaccines.